Thomas Patrick Kelly - Chief Financial Officer at Xenon Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
XENE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Patrick Kelly since 05 Jan 2025

Holdings reported by Thomas Patrick Kelly for Xenon Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Share Option (Right to Buy) 225,000 15 Oct 2025 Direct Common Shares
Restricted Share Units 30,000 15 Oct 2025 Direct Common Shares
No securities are beneficially owned. 0 15 Oct 2025 Direct

Transactions reported by Thomas Patrick Kelly for Xenon Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.